← Eichor
Study identifier: NCT00414115 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children

Condition: Adverse Drug Reaction (ADR)  ·  Sponsor: University of British Columbia

PhaseN/A
Planned participants7000
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

The purpose of the study is (1) to identify and collect samples from children and adults who take drugs and have adverse drug reactions AND children and adults who take drugs and do not experience any adverse drug effects; (2) to determine if genetic differences between the two groups contribute to causing the adverse drug reactions; and (3) to develop patient specific drug dosing guidelines to prevent future adverse drug reactions. We also wish to compare the use of prescription drugs, medical and hospital services and vital statistics between BC participants who experience adverse drug reactions and those who do not. Study hypothesis: Genetic differences may contribute to patients' response to drugs and may be responsible for adverse drug reactions.

This description comes directly from the study's public registry record.

Talk to the study team

Bruce Carleton, PharmD.  ·  604-875-2179  ·  bcarleton@popi.ubc.ca

Always discuss trial participation with your own doctor first.

Locations (1)

Children's and Women's Health Centre of British ColumbiaVancouver, British Columbia, CanadaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT00414115